Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen
- PMID: 1976114
- PMCID: PMC313670
- DOI: 10.1128/iai.58.10.3425-3429.1990
Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen
Abstract
Infection with the blood stage of the malaria parasite Plasmodium vinckei is uniformly lethal in mice. We found that immunization of BALB/c mice with a combination of killed P. vinckei antigens and an attenuated (aroA) Salmonella typhimurium strain induces high levels of protection against challenge with live P. vinckei. This is especially significant because, in our previous studies, immunization of mice with killed P. vinckei antigens and adjuvants such as Bordetella pertussis, complete Freund adjuvant, and saponin failed to induce protective immunity. Immunization with attenuated S. typhimurium alone did not provide any nonspecific immunity. In vivo depletion of CD4+ T cells in the mice immunized with attenuated S. typhimurium and P. vinckei antigens caused the loss of their immunity. Expression of this immunity required the presence of a spleen. These results support our previous hypothesis that a blood stage malaria vaccine may need both induction of CD4+ T cells specific for the parasite and modification of the spleen with a vaccine vehicle. Therefore, attenuated Salmonella strains such as the one used in this study, when expressing recombinant malarial antigens, might fulfill this requirement.
Similar articles
-
Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.J Immunol. 1989 Sep 15;143(6):2017-23. J Immunol. 1989. PMID: 2570802
-
Cellular mechanisms in immunity to blood stage infection.Immunol Lett. 1990 Aug;25(1-3):109-14. doi: 10.1016/0165-2478(90)90100-5. Immunol Lett. 1990. PMID: 1980907 Review.
-
Inability of Plasmodium vinckei-immune spleen cells to transfer protection to recipient mice exposed to vaccine 'vectors' or heterologous species of plasmodium.Parasite Immunol. 1991 Sep;13(5):517-30. doi: 10.1111/j.1365-3024.1991.tb00548.x. Parasite Immunol. 1991. PMID: 1683480
-
Protective immune responses against protease-like antigens of the murine malaria parasite Plasmodium vinckei.Vaccine. 1998 Jul;16(11-12):1193-202. doi: 10.1016/s0264-410x(98)80119-9. Vaccine. 1998. PMID: 9682379
-
Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.Adv Exp Med Biol. 1996;397:15-21. Adv Exp Med Biol. 1996. PMID: 8718577 Review.
Cited by
-
Immune response of pigs to parenteral vaccination with an aromatic-dependent mutant of Salmonella typhimurium.Can J Vet Res. 1992 Oct;56(4):296-302. Can J Vet Res. 1992. PMID: 1477798 Free PMC article.
-
Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection.Infect Immun. 1992 Dec;60(12):5065-70. doi: 10.1128/iai.60.12.5065-5070.1992. Infect Immun. 1992. PMID: 1452338 Free PMC article.
-
Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen.Proc Natl Acad Sci U S A. 1996 May 14;93(10):4595-9. doi: 10.1073/pnas.93.10.4595. Proc Natl Acad Sci U S A. 1996. PMID: 8643449 Free PMC article.
-
Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.Infect Immun. 1997 Aug;65(8):3138-45. doi: 10.1128/iai.65.8.3138-3145.1997. Infect Immun. 1997. PMID: 9234766 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials